Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Q A Mekki

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
The British Journal of Ophthalmology|August 1, 1988
Dopamine-2 receptor blockade does not affect the ocular hypotensive action of timololQ A Mekki, P Turner
British Journal of Clinical Pharmacology|July 1, 1988
Effect of cicloprolol in intraocular pressure in healthy volunteersQ A Mekki, P Turner
Lancet (London, England)|July 28, 1984
Bromocriptine in glaucomaQ A Mekki, P Turner
The British Journal of Ophthalmology|December 1, 1985
Stimulation of dopamine receptors (type 2) lowers human intraocular pressureQ A Mekki, P Turner
Clinical Therapeutics|January 25, 2000
Dose linearity after oral administration of tacrolimus 1-mg capsules at doses of 3, 7, and 10 mgI Bekersky, D Dressler, Q A Mekki
Journal of Clinical Pharmacology|February 24, 2001
Effect of low- and high-fat meals on tacrolimus absorption following 5 mg single oral doses to healthy human subjectsI Bekersky, D Dressler, Q A Mekki
Lancet (London, England)|February 4, 1984
Bromocriptine eyedrops lower intraocular pressure without affecting prolactin levelsQ A Mekki, S J Warrington, P Turner
Lancet (London, England)|June 4, 1983
Bromocriptine lowers intraocular pressure without affecting blood pressureQ A Mekki, S M Hassan, P Turner
British Journal of Clinical Pharmacology|April 1, 1985
Indomethacin does not attenuate the ocular hypotensive effect of timololQ A Mekki, S M Abrams, A D Petounis, et al.
Journal of Clinical Pharmacology|June 14, 2001
Comparative tacrolimus pharmacokinetics: normal versus mildly hepatically impaired subjectsI Bekersky, D Dressler, A Alak, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
The British Journal of Ophthalmology|August 1, 1988
Dopamine-2 receptor blockade does not affect the ocular hypotensive action of timololQ A Mekki, P Turner
British Journal of Clinical Pharmacology|July 1, 1988
Effect of cicloprolol in intraocular pressure in healthy volunteersQ A Mekki, P Turner
Lancet (London, England)|July 28, 1984
Bromocriptine in glaucomaQ A Mekki, P Turner
The British Journal of Ophthalmology|December 1, 1985
Stimulation of dopamine receptors (type 2) lowers human intraocular pressureQ A Mekki, P Turner
Clinical Therapeutics|January 25, 2000
Dose linearity after oral administration of tacrolimus 1-mg capsules at doses of 3, 7, and 10 mgI Bekersky, D Dressler, Q A Mekki
Journal of Clinical Pharmacology|February 24, 2001
Effect of low- and high-fat meals on tacrolimus absorption following 5 mg single oral doses to healthy human subjectsI Bekersky, D Dressler, Q A Mekki
Lancet (London, England)|February 4, 1984
Bromocriptine eyedrops lower intraocular pressure without affecting prolactin levelsQ A Mekki, S J Warrington, P Turner
Lancet (London, England)|June 4, 1983
Bromocriptine lowers intraocular pressure without affecting blood pressureQ A Mekki, S M Hassan, P Turner
British Journal of Clinical Pharmacology|April 1, 1985
Indomethacin does not attenuate the ocular hypotensive effect of timololQ A Mekki, S M Abrams, A D Petounis, et al.
Journal of Clinical Pharmacology|June 14, 2001
Comparative tacrolimus pharmacokinetics: normal versus mildly hepatically impaired subjectsI Bekersky, D Dressler, A Alak, et al.
Pageof 2